Apixaban and Rash maculo-papular - a phase IV clinical study of FDA data

Summary:

Rash maculo-papular is reported as a side effect among people who take Apixaban (apixaban), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Amlodipine, and have Oedema peripheral.

The phase IV clinical study analyzes which people have Rash maculo-papular when taking Apixaban. It is created by eHealthMe based on reports of 60,044 people who have side effects when taking Apixaban from the FDA, and is updated regularly.

What is Apixaban?

Apixaban has active ingredients of apixaban. It is often used in blood clots. eHealthMe is studying from 60,351 Apixaban users. Check the latest studies of Apixaban.

What is Rash maculo-papular?

Rash maculo-papular (red area on the skin that is covered with small confluent bumps) is found to be associated with 1,243 drugs and 1,534 conditions by eHealthMe. Check the latest studies of Rash maculo-papular.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

60,044 people reported to have side effects when taking Apixaban.
Among them, 54 people (0.09%) have Rash maculo-papular.

Could Apixaban cause Rash maculo-papular?

Among these 54 people:

How long have people been on Apixaban when they have Rash maculo-papular? *

What is the gender of people who have Rash maculo-papular when taking Apixaban? *

female: 19.23 %
male: 80.77 %

What is the age of people who have Rash maculo-papular when taking Apixaban? *

What are other drugs people take besides Apixaban? *

What are other side effects people have besides Rash maculo-papular? *

Itching: 25 people, 46.30%
Fever: 17 people, 31.48%
Fatigue (feeling of tiredness): 14 people, 25.93%
Rashes (redness): 11 people, 20.37%
Headache (pain in head): 11 people, 20.37%
Arrhythmias (irregular heartbeat): 11 people, 20.37%
Pain: 11 people, 20.37%
Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 10 people, 18.52%
Diarrhea: 10 people, 18.52%
High Blood Pressure: 10 people, 18.52%

What are the existing conditions these people have? *

Oedema Peripheral (superficial swelling): 11 people, 20.37%
Nausea And Vomiting: 10 people, 18.52%
Pleural Mesothelioma (cancer of the pleura, or the membrane that lines the lungs): 10 people, 18.52%
Enlarged Prostate: 10 people, 18.52%
Jugular Vein Thrombosis (clot in jugular vein): 9 people, 16.67%
Oedema (fluid collection in tissue): 9 people, 16.67%
Pain: 9 people, 16.67%
Anaplastic Thyroid Cancer (thyroid cancer which has a very poor prognosis): 9 people, 16.67%
Thrombosis (formation of a blood clot inside a blood vessel): 9 people, 16.67%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 8 people, 14.81%

* Approximation only. Some reports may have incomplete information.

Do you take Apixaban and have Rash maculo-papular?

- Check whether Rash maculo-papular is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Apixaban:

Apixaban (60,351 reports)

Browse all side effects of Apixaban:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rash maculo-papular:

Rash maculo-papular (1,243 drugs)

Browse all the conditions that are associated with Rash maculo-papular:

Rash maculo-papular (1,534 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on apixaban (the active ingredients of Apixaban) and Apixaban (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.